The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Human Chorionic Gonadotropin-Global Market Insights and Sales Trends 2025
Synopsis
Human chorionic gonadotropin (hCG) belongs to the family of gonadotropin hormones and is naturally produced by the placenta.
The global Human Chorionic Gonadotropin market size is expected to reach US$ 3269.8 million by 2029, growing at a CAGR of 8.1% from 2023 to 2029. The market is mainly driven by the significant applications of Human Chorionic Gonadotropin in various end use industries. The expanding demands from the Fertility Clinics, Research Institutions and Others,, are propelling Human Chorionic Gonadotropin market. Natural Source Extraction, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Recombinant Technology segment is estimated at % CAGR for the next seven-year period.
hCG hormone plays a pivotal role after the formation of the embryo, and hence has gained significant traction over the years for the treatment of infertility in women and men. hCG triggers ovulation in women and assists in increasing the sperm count in men.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Human Chorionic Gonadotropin, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Human Chorionic Gonadotropin market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Human Chorionic Gonadotropin market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Human Chorionic Gonadotropin sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Human Chorionic Gonadotropin covered in this report include Bristol Myers Squibb, Merck & Co, Ferring, Fresenius Kabi and Sun Pharmaceutical, etc.
The global Human Chorionic Gonadotropin market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Bristol Myers Squibb
Merck & Co
Ferring
Fresenius Kabi
Sun Pharmaceutical
Global Human Chorionic Gonadotropin market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Human Chorionic Gonadotropin market, Segment by Type:
Natural Source Extraction
Recombinant Technology
Global Human Chorionic Gonadotropin market, by Application
Fertility Clinics
Research Institutions
Others
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Human Chorionic Gonadotropin companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Human chorionic gonadotropin (hCG) belongs to the family of gonadotropin hormones and is naturally produced by the placenta.
The global Human Chorionic Gonadotropin market size is expected to reach US$ 3269.8 million by 2029, growing at a CAGR of 8.1% from 2023 to 2029. The market is mainly driven by the significant applications of Human Chorionic Gonadotropin in various end use industries. The expanding demands from the Fertility Clinics, Research Institutions and Others,, are propelling Human Chorionic Gonadotropin market. Natural Source Extraction, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Recombinant Technology segment is estimated at % CAGR for the next seven-year period.
hCG hormone plays a pivotal role after the formation of the embryo, and hence has gained significant traction over the years for the treatment of infertility in women and men. hCG triggers ovulation in women and assists in increasing the sperm count in men.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Human Chorionic Gonadotropin, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Human Chorionic Gonadotropin market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Human Chorionic Gonadotropin market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Human Chorionic Gonadotropin sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Human Chorionic Gonadotropin covered in this report include Bristol Myers Squibb, Merck & Co, Ferring, Fresenius Kabi and Sun Pharmaceutical, etc.
The global Human Chorionic Gonadotropin market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Bristol Myers Squibb
Merck & Co
Ferring
Fresenius Kabi
Sun Pharmaceutical
Global Human Chorionic Gonadotropin market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Human Chorionic Gonadotropin market, Segment by Type:
Natural Source Extraction
Recombinant Technology
Global Human Chorionic Gonadotropin market, by Application
Fertility Clinics
Research Institutions
Others
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Human Chorionic Gonadotropin companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Human Chorionic Gonadotropin
1.1 Human Chorionic Gonadotropin Market Overview
1.1.1 Human Chorionic Gonadotropin Product Scope
1.1.2 Human Chorionic Gonadotropin Market Status and Outlook
1.2 Global Human Chorionic Gonadotropin Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Human Chorionic Gonadotropin Market Size by Region (2018-2029)
1.4 Global Human Chorionic Gonadotropin Historic Market Size by Region (2018-2023)
1.5 Global Human Chorionic Gonadotropin Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Human Chorionic Gonadotropin Market Size (2018-2029)
1.6.1 North America Human Chorionic Gonadotropin Market Size (2018-2029)
1.6.2 Europe Human Chorionic Gonadotropin Market Size (2018-2029)
1.6.3 Asia-Pacific Human Chorionic Gonadotropin Market Size (2018-2029)
1.6.4 Latin America Human Chorionic Gonadotropin Market Size (2018-2029)
1.6.5 Middle East & Africa Human Chorionic Gonadotropin Market Size (2018-2029)
2 Human Chorionic Gonadotropin Market by Type
2.1 Introduction
2.1.1 Natural Source Extraction
2.1.2 Recombinant Technology
2.2 Global Human Chorionic Gonadotropin Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Human Chorionic Gonadotropin Historic Market Size by Type (2018-2023)
2.2.2 Global Human Chorionic Gonadotropin Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Human Chorionic Gonadotropin Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Human Chorionic Gonadotropin Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Human Chorionic Gonadotropin Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Human Chorionic Gonadotropin Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Human Chorionic Gonadotropin Revenue Breakdown by Type (2018-2029)
3 Human Chorionic Gonadotropin Market Overview by Application
3.1 Introduction
3.1.1 Fertility Clinics
3.1.2 Research Institutions
3.1.3 Others
3.2 Global Human Chorionic Gonadotropin Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Human Chorionic Gonadotropin Historic Market Size by Application (2018-2023)
3.2.2 Global Human Chorionic Gonadotropin Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Human Chorionic Gonadotropin Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Human Chorionic Gonadotropin Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Human Chorionic Gonadotropin Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Human Chorionic Gonadotropin Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Human Chorionic Gonadotropin Revenue Breakdown by Application (2018-2029)
4 Human Chorionic Gonadotropin Competition Analysis by Players
4.1 Global Human Chorionic Gonadotropin Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Human Chorionic Gonadotropin as of 2022)
4.3 Date of Key Players Enter into Human Chorionic Gonadotropin Market
4.4 Global Top Players Human Chorionic Gonadotropin Headquarters and Area Served
4.5 Key Players Human Chorionic Gonadotropin Product Solution and Service
4.6 Competitive Status
4.6.1 Human Chorionic Gonadotropin Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Bristol Myers Squibb
5.1.1 Bristol Myers Squibb Profile
5.1.2 Bristol Myers Squibb Main Business
5.1.3 Bristol Myers Squibb Human Chorionic Gonadotropin Products, Services and Solutions
5.1.4 Bristol Myers Squibb Human Chorionic Gonadotropin Revenue (US$ Million) & (2018-2023)
5.1.5 Bristol Myers Squibb Recent Developments
5.2 Merck & Co
5.2.1 Merck & Co Profile
5.2.2 Merck & Co Main Business
5.2.3 Merck & Co Human Chorionic Gonadotropin Products, Services and Solutions
5.2.4 Merck & Co Human Chorionic Gonadotropin Revenue (US$ Million) & (2018-2023)
5.2.5 Merck & Co Recent Developments
5.3 Ferring
5.3.1 Ferring Profile
5.3.2 Ferring Main Business
5.3.3 Ferring Human Chorionic Gonadotropin Products, Services and Solutions
5.3.4 Ferring Human Chorionic Gonadotropin Revenue (US$ Million) & (2018-2023)
5.3.5 Fresenius Kabi Recent Developments
5.4 Fresenius Kabi
5.4.1 Fresenius Kabi Profile
5.4.2 Fresenius Kabi Main Business
5.4.3 Fresenius Kabi Human Chorionic Gonadotropin Products, Services and Solutions
5.4.4 Fresenius Kabi Human Chorionic Gonadotropin Revenue (US$ Million) & (2018-2023)
5.4.5 Fresenius Kabi Recent Developments
5.5 Sun Pharmaceutical
5.5.1 Sun Pharmaceutical Profile
5.5.2 Sun Pharmaceutical Main Business
5.5.3 Sun Pharmaceutical Human Chorionic Gonadotropin Products, Services and Solutions
5.5.4 Sun Pharmaceutical Human Chorionic Gonadotropin Revenue (US$ Million) & (2018-2023)
5.5.5 Sun Pharmaceutical Recent Developments
6 North America
6.1 North America Human Chorionic Gonadotropin Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Human Chorionic Gonadotropin Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Human Chorionic Gonadotropin Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Human Chorionic Gonadotropin Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Human Chorionic Gonadotropin Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Human Chorionic Gonadotropin Market Dynamics
11.1 Human Chorionic Gonadotropin Industry Trends
11.2 Human Chorionic Gonadotropin Market Drivers
11.3 Human Chorionic Gonadotropin Market Challenges
11.4 Human Chorionic Gonadotropin Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Chemicals Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
